Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation

BACKGROUND: Delayed graft function, the requirement for dialysis due to poor kidney function post-transplant, is a frequent complication of deceased donor kidney transplantation and is associated with inferior outcomes and higher costs. Intravenous fluids given during and after transplantation may a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Trials
Autori principali: Collins, Michael G., Fahim, Magid A., Pascoe, Elaine M., Dansie, Kathryn B., Hawley, Carmel M., Clayton, Philip A., Howard, Kirsten, Johnson, David W., McArthur, Colin J., McConnochie, Rachael C., Mount, Peter F., Reidlinger, Donna, Robison, Laura, Varghese, Julie, Vergara, Liza A., Weinberg, Laurence, Chadban, Steven J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7249430/
https://ncbi.nlm.nih.gov/pubmed/32450917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04359-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi